Effects of Unfractionated and Low Molecular Heparins on Thromboxane Biosynthesis "In Vivo"
1994-01-01 Landolfi, R; De Candia, E; Rocca, B; Ciabattoni, G; Antinori, A; Masetti, R; Patrono, C
Symply read: erythrocytes modulate platelet function. should we rethink the way we give aspirin?
1997-01-01 Rocca, B; Fitzgerald, Ga
Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing
2022-01-01 Giaretta, A; Petrucci, G; Rocca, B; Toffolo, Gm.
Antithrombotic therapy and revascularisation strategies in people with diabetes and coronary artery disease
2019-01-01 Rocca, B; Rubboli, A; Zaccardi, F.
Wiskott-Aldrich syndrome: report of an autosomal dominant variant
1996-01-01 Rocca, B; Bellacosa, A; De Cristofaro, R; Della Ventura, M; Maggiano, N; Rumi, C and Landolfi R
Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo
2000-01-01 Audoly, L; Rocca, B; Loeb, Al; Coffman TM and FitzGerald GA (Audoly L and Rocca, B equal Contributors)
Effect of fibrinogen concentration on the velocity of platelet aggregation
1991-01-01 Landolfi, R; De Cristofaro, R; De Candia, E; Rocca, B; Bizzi, B
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer
2022-01-01 Falanga, A; Leader, A; Ambaglio, C; Bagoly, Z; Castaman, G; Elalamy, I; Lecumberri, R; Niessner, A; Pabinger, I; Szmit, S; Trinchero, A; Ten Cate, H; Rocca, B
A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes
2018-01-01 van Zuydam, Nr; Ahlqvist, E; Sandholm, N; Deshmukh, H; Rayner, Nw; Abdalla, M; Ladenvall, C; Ziemek, D; Fauman, E; Robertson, Nr; Mckeigue, Pm; Valo, E; Forsblom, C; Harjutsalo, V; Finnish Diabetic Nephropathy Study, (FinnDiane); Perna, A; Rurali, E; Marcovecchio, Ml; Igo RP, Jr; Salem, Rm; Perico, N; Lajer, M; Käräjämäki, A; Imamura, M; Kubo, M; Takahashi, A; Sim, X; Liu, J; van Dam, Rm; Jiang, G; Tam, Cht; Luk, Aoy; Lee, Hm; Lim, Ckp; Szeto, Cc; So, Wy; Chan, Jcn; Hong Kong Diabetes Registry Theme-based Research Scheme Project, Group; Ang, Sf; Dorajoo, R; Wang, L; Clara, Tsh; Mcknight, Aj; Duffy, S; Warren, 3 and Genetics of Kidneys in Diabetes (GoKinD) Study Group; Pezzolesi, Mg; GENIE (GEnetics of Nephropathy an International Effort), Consortium; Marre, M; Gyorgy, B; Hadjadj, S; Hiraki, Lt; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research, Group; Ahluwalia, Ts; Almgren, P; Schulz, Ca; Orho-Melander, M; Linneberg, A; Christensen, C; Witte, Dr; Grarup, N; Brandslund, I; Melander, O; Paterson, Ad; Tregouet, D; Maxwell, Ap; Lim, Sc; Ma, Rcw; Tai, Es; Maeda, S; Lyssenko, V; Tuomi, T; Krolewski, As; Rich, Ss; Hirschhorn, Jn; Florez, Jc; Dunger, D; Pedersen, O; Hansen, T; Rossing, P; Remuzzi, G; SUrrogate markers for Micro- and Macrovascular hard endpoints for Innovative diabetes Tools (SUMMIT), Consortium; Rocca, B; Brosnan, Mj; Palmer, Cna; Groop, Ph; Colhoun, Hm; Groop, Lc; McCarthy MI., Rocca B part of the SUMMIT Consortium
Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis
2015-01-01 Zaccardi, F; Rocca, B; Pitocco, D; Tanese, L; Rizzi, A; Ghirlanda, G
TNF-related apoptosis-inducing ligand (TRAIL) up-regulates cyclooxygenase (COX)-1 activity and PGE(2) production in cells of the myeloid lineage
2002-01-01 Secchiero, P; Gonelli, A; Ciabattoni, G; Melloni, E; Grill, V; Rocca, B; Delbello, G; Zauli, G
Illustrated State-of-the-Art Capsules of the ISTH 2022 Congress
2022-01-01 Ariëns, R. A.; Hunt, B. J.; Agbani, E. O.; Rocca, B; Zafar, T.; Zhou, J.
Autosomal-dominant giant platelet syndromes: a hint of the same genetic defect as in Fechtner syndrome owing to a similar genetic linkage to chromosome 22q11-13
2000-01-01 Toren, A; Rozenfeld-Granot, G; Rocca, B; Epstein, Cj; Amariglio, N; Laghi, F; Landolfi, R; Brok-Simoni, F; Carlsson, Le; Rechavi, G; Greinacher, A
MYH9 spectrum of autosomal-dominant giant platelet syndromes: Unexpected association with fibulin-1 variant-D inactivation
2003-01-01 Toren, A; Rozenfeld-Granot, G; Heath, Ke; Amariglio, N; Rocca, B; Crosson, J; Epstein, Cj; Laghi, F; Landolfi, R; Carlsson, Le; Argraves, S; Bizzaro, N; Moxey-Mims, M; Brok-Simoni, F; Martignetti, Ja; Greinacher, A; Rechavi, G
Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia
2009-01-01 Liu, K; Martini, M; Rocca, B; Amos, Ci; Teofili, L; Giona, F; Ding, J; Komatsu, H; Larocca, Lm; Skoda, Rc
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome
2019-01-01 Parker, William A. E.; Orme, Rachel C.; Hanson, Jessica; Stokes, Hannah M.; Bridge, Claire M.; Shaw, Patricia A.; Sumaya, Wael; Thorneycroft, Kirstie; Petrucci, Giovanna; Porro, Benedetta; Judge, Heather M.; Ajjan, Ramzi A.; Rocca, Bianca; Storey, Robert F.
Increased Von Willebrand Factor levels in Polycythemia Vera and phenotypic differences with Essential Thrombocythemia
2020-01-01 Sacco, M; Ranalli, P; Lancellotti, S; Petrucci, G; Dragani, A; Rocca, B; De Cristofaro R., (Rocca B Corresponding Author)
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a Joint Position Paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
2021-01-01 Gorog, Da; Price, S; Sibbing, D; Baumbach, A; Capodanno, D; Gigante, B; Halvorsen, S; Huber, K; Lettino, M; Leonardi, S; Morais, J; Rubboli, A; Siller-Matula, Jm; Storey, Rf; Vranckx, P; Rocca, B
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis
2017-01-01 Halvorsen, S; Storey, Rf; Rocca, B; Sibbing, D; Ten Berg, J; Grove, El; Weiss, Tw; Collet, Jp; Andreotti, F; Gulba, Dc; Lip, Gy; Husted, S; Vilahur, G; Morais, J; Verheugt, Fw; Lanas, A; Al-Shahi Salman, R; Steg, Pg; Huber, K
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases
2022-01-01 Petrucci, Giovanna; Rizzi, Alessandro; Hatem, Duaa; Tosti, Giulia; Rocca, Bianca; Pitocco, Dario
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Effects of Unfractionated and Low Molecular Heparins on Thromboxane Biosynthesis "In Vivo" | 1-gen-1994 | Landolfi, R; De Candia, E; Rocca, B; Ciabattoni, G; Antinori, A; Masetti, R; Patrono, C | |
| Symply read: erythrocytes modulate platelet function. should we rethink the way we give aspirin? | 1-gen-1997 | Rocca, B; Fitzgerald, Ga | |
| Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing | 1-gen-2022 | Giaretta, A; Petrucci, G; Rocca, B; Toffolo, Gm. | |
| Antithrombotic therapy and revascularisation strategies in people with diabetes and coronary artery disease | 1-gen-2019 | Rocca, B; Rubboli, A; Zaccardi, F. | |
| Wiskott-Aldrich syndrome: report of an autosomal dominant variant | 1-gen-1996 | Rocca, B; Bellacosa, A; De Cristofaro, R; Della Ventura, M; Maggiano, N; Rumi, C and Landolfi R | |
| Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo | 1-gen-2000 | Audoly, L; Rocca, B; Loeb, Al; Coffman TM and FitzGerald GA (Audoly L and Rocca, B equal Contributors) | |
| Effect of fibrinogen concentration on the velocity of platelet aggregation | 1-gen-1991 | Landolfi, R; De Cristofaro, R; De Candia, E; Rocca, B; Bizzi, B | |
| EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer | 1-gen-2022 | Falanga, A; Leader, A; Ambaglio, C; Bagoly, Z; Castaman, G; Elalamy, I; Lecumberri, R; Niessner, A; Pabinger, I; Szmit, S; Trinchero, A; Ten Cate, H; Rocca, B | |
| A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes | 1-gen-2018 | van Zuydam, Nr; Ahlqvist, E; Sandholm, N; Deshmukh, H; Rayner, Nw; Abdalla, M; Ladenvall, C; Ziemek, D; Fauman, E; Robertson, Nr; Mckeigue, Pm; Valo, E; Forsblom, C; Harjutsalo, V; Finnish Diabetic Nephropathy Study, (FinnDiane); Perna, A; Rurali, E; Marcovecchio, Ml; Igo RP, Jr; Salem, Rm; Perico, N; Lajer, M; Käräjämäki, A; Imamura, M; Kubo, M; Takahashi, A; Sim, X; Liu, J; van Dam, Rm; Jiang, G; Tam, Cht; Luk, Aoy; Lee, Hm; Lim, Ckp; Szeto, Cc; So, Wy; Chan, Jcn; Hong Kong Diabetes Registry Theme-based Research Scheme Project, Group; Ang, Sf; Dorajoo, R; Wang, L; Clara, Tsh; Mcknight, Aj; Duffy, S; Warren, 3 and Genetics of Kidneys in Diabetes (GoKinD) Study Group; Pezzolesi, Mg; GENIE (GEnetics of Nephropathy an International Effort), Consortium; Marre, M; Gyorgy, B; Hadjadj, S; Hiraki, Lt; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research, Group; Ahluwalia, Ts; Almgren, P; Schulz, Ca; Orho-Melander, M; Linneberg, A; Christensen, C; Witte, Dr; Grarup, N; Brandslund, I; Melander, O; Paterson, Ad; Tregouet, D; Maxwell, Ap; Lim, Sc; Ma, Rcw; Tai, Es; Maeda, S; Lyssenko, V; Tuomi, T; Krolewski, As; Rich, Ss; Hirschhorn, Jn; Florez, Jc; Dunger, D; Pedersen, O; Hansen, T; Rossing, P; Remuzzi, G; SUrrogate markers for Micro- and Macrovascular hard endpoints for Innovative diabetes Tools (SUMMIT), Consortium; Rocca, B; Brosnan, Mj; Palmer, Cna; Groop, Ph; Colhoun, Hm; Groop, Lc; McCarthy MI., Rocca B part of the SUMMIT Consortium | |
| Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis | 1-gen-2015 | Zaccardi, F; Rocca, B; Pitocco, D; Tanese, L; Rizzi, A; Ghirlanda, G | |
| TNF-related apoptosis-inducing ligand (TRAIL) up-regulates cyclooxygenase (COX)-1 activity and PGE(2) production in cells of the myeloid lineage | 1-gen-2002 | Secchiero, P; Gonelli, A; Ciabattoni, G; Melloni, E; Grill, V; Rocca, B; Delbello, G; Zauli, G | |
| Illustrated State-of-the-Art Capsules of the ISTH 2022 Congress | 1-gen-2022 | Ariëns, R. A.; Hunt, B. J.; Agbani, E. O.; Rocca, B; Zafar, T.; Zhou, J. | |
| Autosomal-dominant giant platelet syndromes: a hint of the same genetic defect as in Fechtner syndrome owing to a similar genetic linkage to chromosome 22q11-13 | 1-gen-2000 | Toren, A; Rozenfeld-Granot, G; Rocca, B; Epstein, Cj; Amariglio, N; Laghi, F; Landolfi, R; Brok-Simoni, F; Carlsson, Le; Rechavi, G; Greinacher, A | |
| MYH9 spectrum of autosomal-dominant giant platelet syndromes: Unexpected association with fibulin-1 variant-D inactivation | 1-gen-2003 | Toren, A; Rozenfeld-Granot, G; Heath, Ke; Amariglio, N; Rocca, B; Crosson, J; Epstein, Cj; Laghi, F; Landolfi, R; Carlsson, Le; Argraves, S; Bizzaro, N; Moxey-Mims, M; Brok-Simoni, F; Martignetti, Ja; Greinacher, A; Rechavi, G | |
| Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia | 1-gen-2009 | Liu, K; Martini, M; Rocca, B; Amos, Ci; Teofili, L; Giona, F; Ding, J; Komatsu, H; Larocca, Lm; Skoda, Rc | |
| Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome | 1-gen-2019 | Parker, William A. E.; Orme, Rachel C.; Hanson, Jessica; Stokes, Hannah M.; Bridge, Claire M.; Shaw, Patricia A.; Sumaya, Wael; Thorneycroft, Kirstie; Petrucci, Giovanna; Porro, Benedetta; Judge, Heather M.; Ajjan, Ramzi A.; Rocca, Bianca; Storey, Robert F. | |
| Increased Von Willebrand Factor levels in Polycythemia Vera and phenotypic differences with Essential Thrombocythemia | 1-gen-2020 | Sacco, M; Ranalli, P; Lancellotti, S; Petrucci, G; Dragani, A; Rocca, B; De Cristofaro R., (Rocca B Corresponding Author) | |
| Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a Joint Position Paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI) | 1-gen-2021 | Gorog, Da; Price, S; Sibbing, D; Baumbach, A; Capodanno, D; Gigante, B; Halvorsen, S; Huber, K; Lettino, M; Leonardi, S; Morais, J; Rubboli, A; Siller-Matula, Jm; Storey, Rf; Vranckx, P; Rocca, B | |
| Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis | 1-gen-2017 | Halvorsen, S; Storey, Rf; Rocca, B; Sibbing, D; Ten Berg, J; Grove, El; Weiss, Tw; Collet, Jp; Andreotti, F; Gulba, Dc; Lip, Gy; Husted, S; Vilahur, G; Morais, J; Verheugt, Fw; Lanas, A; Al-Shahi Salman, R; Steg, Pg; Huber, K | |
| Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases | 1-gen-2022 | Petrucci, Giovanna; Rizzi, Alessandro; Hatem, Duaa; Tosti, Giulia; Rocca, Bianca; Pitocco, Dario |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista10032
Data di pubblicazione
- In corso di stampa26
- 2020 - 20264513
- 2010 - 20193759
- 2000 - 20091284
- 1990 - 1999374
- 1980 - 198975
- 1977 - 19791
Rivista
- INTERNATIONAL JOURNAL OF MOLECULA...112
- JOURNAL OF CLINICAL MEDICINE96
- PLOS ONE79
- EUROPEAN HEART JOURNAL69
- CANCERS64
- NUTRIENTS64
- THROMBOSIS AND HAEMOSTASIS60
- MOVEMENT DISORDERS56
- NMCD. NUTRITION METABOLISM AND CA...56
- SCIENTIFIC REPORTS56
Keyword
- Humans317
- Male154
- Female147
- COVID-19124
- Aged108
- Middle Aged99
- Italy94
- Cardiology and Cardiovascular Med...88
- Adult85
- Medicine (all)61
Lingua
- eng6258
- ita928
- fre12
- spa11
- ger3
- und2
- afr1
- bul1
- lat1
Accesso al fulltext
- no fulltext10032